Buspirone, Stress, and Attentional Bias to Marijuana Cues
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This project has two primary goals. The first goal is to further scientific understanding
about marijuana abuse by examining two recognized factors in marijuana use and relapse: (1)
stress/anxiety and (2) atypical reactivity to marijuana-related stimuli (e.g., attentional
bias). The second goal is to attenuate the influence of stress/anxiety and attentional bias
to marijuana stimuli via administration of buspirone.
Buspirone is uniquely suited to this project because it has effects on neurotransmitter
systems known to modulate both stress/anxiety and attentional bias.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston